Injective Soars with Coinbase Integration

Injective (INJ) has regained momentum after months under pressure. The token posted steady gains over the past month, climbing to $5.14 at the time of writing.

This recovery comes as Coinbase expanded support for native INJ, a development that removes a key barrier for users looking to move assets directly on the Injective blockchain.

Coinbase has completed its migration from the ERC-20 version of INJ to the native Injective token, automatically converting customer balances on a one-to-one basis. This means Coinbase users can now trade INJ and move it directly into the Injective ecosystem through seamless deposits and withdrawals.